Abstract:Dear Editor, We read with great interest the report by Fu et al on the investigation of the prognostic value of the lymph node (LN) station ratio (SR, metastatic LN stations/examined LN stations) in esophageal squamous cell carcinoma (ESCC) patients. This study developed a new N category, which was demonstrated to provide more detailed prognostic information than the current N category. A standard staging system should be encompass the following major aspects: (1) the difference in survival time is small among patients classified into the same group by that criterion (homogeneity); (2) there are much greater differences in the survival times among patients classified into different groups (discriminatory ability); (3) mean survival time for a group classified as favorable is longer than the survival time for less favorable groups (monotonicity of gradients). In this study, log-rank test and c-index were used for measuring both the discriminatory power and monotonicity of the gradient, and the homogeneity was explored by performing the likelihood ratio (LR) test. Thus, this study has demonstrated statistically convincing evidence for that SR category has a superior prognostic ability relative to the AJCC pN category in ESCC patients. However, some points of the manuscript warrant discussion. First, since the radical two-field lymph node dissection with a qualified number of resected lymph nodes (>15) was done for each patient included, the value of LN stations was confinedwithin a certain narrow range (median 7, mean ± SD 7.67 ± 2.25). In this case, the prognostic power of examined LN stations was limited considerably, and the main determinant of SR was the metastatic LN stations. Second, the authors did not describe the process to select the arithmetic method to describe metastatic LN stations and examined LN stations. Readers might argue that other statistical models should be examined, such as arithmetic addition (metastatic stations + 1/ examined stations). Simple combination may produce adverse effects by impairing the homogeneity, discrimination, or monotonicity of each predictable marker. To further prove the point that the SR stage can properly represent both the quantitative accuracy and extent of LN metastasis, evaluation of the separate prognostic performance of examined LN stations and metastatic LN stations is mandatory to be added in the results section Another notable limitation is the lack of an external validation cohort to access the prognostic performance of this modified N category. A validation cohort is needed to further prove the improved prognostic ability of the new T-SR-M staging system into daily clinical practice. In short, the authors have proposed a revised N category which was demonstrated with a superior prognostic ability as compared with the AJCC pN category in ESCC patients after radical esophagectomy. Given the above-mentioned potential limitations, the prognostic power of this new N staging needs further investigation.

Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?

Assessment of Lymph Node Ratio to Replace the Pn Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.

Lymph Node Ratio-Based Staging System for Esophageal Squamous Cell Carcinoma

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

Lymph Node Station Ratio: Revised Nodal Category for Resected Esophageal Squamous Cell Carcinoma Patients

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

Lymph Node Ratio Precisely Predicts the Benefit of Postoperative Radiotherapy in Esophageal Cancer: A Retrospective Cohort Study

Log Odds of Positive Lymph Nodes Predicts Survival in Patients after Resection for Esophageal Cancer.

Prognostic Power of Lymph Node Station Ratio for Resected Esophageal Squamous Cell Carcinoma Patients Deserves Additional Investigation

The Positive Lymph Node Ratio Predicts Long-Term Survival in Patients with Operable Thoracic Esophageal Squamous Cell Carcinoma in China

Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations

Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.

Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis

Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy

Prognostic Role of Neutrophil-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma

Prognostic Significance of Preoperative Lymphocyte-Monocyte Ratio in Patients with Resectable Esophageal Squamous Cell Carcinoma.

Use Of The Metastatic Lymph Node Ratio To Evaluate The Prognosis Of Esophageal Cancer Patients With Node Metastasis Following Radical Esophagectomy

Clinical and Prognostic Significance of Preoperative Lymphocyte-Monocyte Ratio, Neutrophil-Lymphocyte Ratio and Neutrophil-Monocyte Ratio on Esophageal Squamous Cell Carcinoma Patients

Comparison of three lymph node staging systems in evaluating the prognosis of patients with pT3 esophageal squamous cell carcinoma

Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio

The N-Classification for Esophageal Cancer Staging: Should it be Based on Number, Distance, or Extent of the Lymph Node Metastasis?